HomeRNA • NASDAQ
add
Avidity Biosciences Inc
Previous close
$35.59
Day range
$35.87 - $36.99
Year range
$21.51 - $55.98
Market cap
4.37B USD
Avg Volume
1.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.57M | -55.60% |
Operating expense | 33.60M | 141.76% |
Net income | -115.77M | -68.14% |
Net profit margin | -7.36K | -278.72% |
Earnings per share | -0.90 | -13.92% |
EBITDA | -130.73M | -70.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.38B | 50.66% |
Total assets | 1.46B | 53.35% |
Total liabilities | 130.35M | 8.11% |
Total equity | 1.33B | — |
Shares outstanding | 120.54M | — |
Price to book | 3.23 | — |
Return on assets | -21.75% | — |
Return on capital | -23.77% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -115.77M | -68.14% |
Cash from operations | -124.83M | -77.36% |
Cash from investing | 157.19M | 580.01% |
Cash from financing | 1.94M | -99.50% |
Net change in cash | 34.34M | -88.01% |
Free cash flow | -94.93M | -103.42% |
About
CEO
Founded
2012
Website
Employees
391
